Heidi Nelson to Female
This is a "connection" page, showing publications Heidi Nelson has written about Female.
Connection Strength
2.965
-
Barriers and Facilitators to Screening for Anxiety and Intimate Partner Violence. J Am Board Fam Med. 2026 Feb 27; 38(6):1049-1063.
Score: 0.081
-
Patient Navigation Services for Breast and Cervical Cancer Screening and Follow-Up: A Meta-Analysis. JAMA Intern Med. 2025 Aug 01; 185(8):976-985.
Score: 0.078
-
Quality of Cancer Recurrence Data in the National Cancer Database: A Reappraisal of Reporting Readiness. Ann Surg Oncol. 2025 Mar; 32(3):1553-1564.
Score: 0.075
-
Survival Among Patients With High-Risk Gastrointestinal Cancers During the COVID-19 Pandemic. JAMA Netw Open. 2024 Mar 04; 7(3):e240160.
Score: 0.071
-
Unintended Pregnancy and Maternal and Infant Health Outcomes-Reply. JAMA. 2023 03 07; 329(9):765-766.
Score: 0.066
-
Associations of Unintended Pregnancy With Maternal and Infant Health Outcomes: A Systematic Review and Meta-analysis. JAMA. 2022 11 01; 328(17):1714-1729.
Score: 0.065
-
Well-Woman Chart Is Useful in Guiding Preventive Care. Am Fam Physician. 2021 07 01; 104(1):9-10.
Score: 0.059
-
Effectiveness of Patient Navigation to Increase Cancer Screening in Populations Adversely Affected by Health Disparities: a Meta-analysis. J Gen Intern Med. 2020 10; 35(10):3026-3035.
Score: 0.055
-
Screening for Anxiety in Adolescent and Adult Women: A Systematic Review for the Women's Preventive Services Initiative. Ann Intern Med. 2020 07 07; 173(1):29-41.
Score: 0.055
-
NASA-Task Load Index Differentiates Surgical Approach: Opportunities for Improvement in Colon and Rectal Surgery. Ann Surg. 2020 05; 271(5):906-912.
Score: 0.054
-
NASA-TLX Assessment of Surgeon Workload Variation Across Specialties. Ann Surg. 2020 04; 271(4):686-692.
Score: 0.054
-
Use of an Online Breast Cancer Risk Assessment and Patient Decision Aid in Primary Care Practices. J Womens Health (Larchmt). 2020 06; 29(6):763-769.
Score: 0.054
-
Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2019 09 03; 322(9):868-886.
Score: 0.052
-
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2019 08 20; 322(7):666-685.
Score: 0.052
-
Surgeon Workload in Colorectal Surgery: Perceived Drivers of Procedural Difficulty. J Surg Res. 2020 01; 245:57-63.
Score: 0.052
-
Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012-2014. Ann Surg Oncol. 2019 Jun; 26(6):1604-1612.
Score: 0.050
-
Assessment of a Personalized Approach to Predicting Postprandial Glycemic Responses to Food Among Individuals Without Diabetes. JAMA Netw Open. 2019 02 01; 2(2):e188102.
Score: 0.050
-
Screening for Urinary Incontinence in Women: A Systematic Review for the Women's Preventive Services Initiative. Ann Intern Med. 2018 09 04; 169(5):311-319.
Score: 0.048
-
Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial. Ann Surg. 2017 01; 265(1):192-196.
Score: 0.043
-
Mammography Screening and Overdiagnosis. JAMA Oncol. 2016 Feb; 2(2):261-2.
Score: 0.041
-
Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2016 Feb 16; 164(4):244-55.
Score: 0.040
-
Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2016 Feb 16; 164(4):256-67.
Score: 0.040
-
Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data. Ann Intern Med. 2016 Feb 16; 164(4):226-35.
Score: 0.040
-
Mammography Decision Aid Reduces Decisional Conflict for Women in Their Forties Considering Screening. J Womens Health (Larchmt). 2015 Dec; 24(12):1013-20.
Score: 0.039
-
Young Age and Aggressive Treatment in Colon Cancer. JAMA. 2015 Aug 11; 314(6):613-4.
Score: 0.039
-
Mammography Screening in a Large Health System Following the U.S. Preventive Services Task Force Recommendations and the Affordable Care Act. PLoS One. 2015; 10(6):e0131903.
Score: 0.039
-
Screening for gonorrhea and Chlamydia: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014 Dec 16; 161(12):884-93.
Score: 0.037
-
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med. 2014 Feb 18; 160(4):255-66.
Score: 0.035
-
Rates and indications for surgical breast biopsies in a community-based health system. Am J Surg. 2014 Apr; 207(4):499-503.
Score: 0.035
-
Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013 Apr 16; 158(8):604-14.
Score: 0.033
-
Menopausal hormone therapy and primary prevention. Ann Intern Med. 2013 Jan 15; 158(2):141.
Score: 0.033
-
Surgical quality surrogates do not predict colon cancer survival in the setting of technical credentialing: a report from the prospective COST trial. Ann Surg. 2013 Jan; 257(1):102-7.
Score: 0.033
-
Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations. Ann Intern Med. 2012 Jul 17; 157(2):104-13.
Score: 0.032
-
Screening women for intimate partner violence: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med. 2012 Jun 05; 156(11):796-808, W-279, W-280, W-281, W-282.
Score: 0.031
-
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med. 2012 May 01; 156(9):635-48.
Score: 0.031
-
Screening for osteoporosis: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2010 Jul 20; 153(2):99-111.
Score: 0.028
-
Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer. Ann Intern Med. 2009 Nov 17; 151(10):703-15, W-226-35.
Score: 0.026
-
Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009 Nov 17; 151(10):727-37, W237-42.
Score: 0.026
-
Laparoscopic-assisted proctectomy for rectal cancer: on trial. Ann Surg Oncol. 2008 Sep; 15(9):2357-9.
Score: 0.024
-
Menopause. Lancet. 2008 Mar 01; 371(9614):760-70.
Score: 0.023
-
Estimating risk of breast cancer in carriers of BRCA1 and BRCA2 mutations: a meta-analytic approach. Stat Med. 2007 Apr 15; 26(8):1775-87.
Score: 0.022
-
Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med. 2006 Jul 24; 166(14):1453-65.
Score: 0.021
-
Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA. 2006 May 03; 295(17):2057-71.
Score: 0.021
-
Screening for Cervical Cancer: A Recommendation From the Women's Preventive Services Initiative. Obstet Gynecol. 2026 Jul 01; 148(1):e3-e13.
Score: 0.021
-
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2005 Sep 06; 143(5):362-79.
Score: 0.020
-
Beyond TNM staging: Machine learning of individualized colon cancer outcomes. Surgery. 2025 Oct; 186:109571.
Score: 0.020
-
Recommendations From the Women's Preventive Services Initiative on Breast Cancer Screening for Women at Average Risk and Patient Navigation Services for Breast and Cervical Cancer Screening. Obstet Gynecol. 2025 Jul 17; 146(3):315-322.
Score: 0.020
-
Screening for domestic violence--bridging the evidence gaps. Lancet. 2004 Dec; 364 Suppl 1:s22-3.
Score: 0.019
-
Gut Microbiome Wellness Index 2 enhances health status prediction from gut microbiome taxonomic profiles. Nat Commun. 2024 Aug 28; 15(1):7447.
Score: 0.018
-
Cancer Survivorship Care in the United States at Facilities Accredited by the Commission on Cancer. JAMA Netw Open. 2024 Jul 01; 7(7):e2418736.
Score: 0.018
-
Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA. 2004 Apr 07; 291(13):1610-20.
Score: 0.018
-
Postmenopausal estrogen for treatment of hot flashes: clinical applications. JAMA. 2004 Apr 07; 291(13):1621-5.
Score: 0.018
-
Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants. JAMA Netw Open. 2024 Apr 01; 7(4):e247421.
Score: 0.018
-
Screening women and elderly adults for family and intimate partner violence: a review of the evidence for the U. S. Preventive Services Task Force. Ann Intern Med. 2004 Mar 02; 140(5):387-96.
Score: 0.018
-
Alterations in Cancer Treatment During the First Year of the COVID-19 Pandemic in the US. JAMA Netw Open. 2023 10 02; 6(10):e2340148.
Score: 0.017
-
Postmenopausal osteoporosis and estrogen. Am Fam Physician. 2003 Aug 15; 68(4):606, 610, 612.
Score: 0.017
-
Update in women's health. Ann Intern Med. 2003 Jan 21; 138(2):119-27.
Score: 0.016
-
Osteoporosis and fractures in postmenopausal women using estrogen. Arch Intern Med. 2002 Nov 11; 162(20):2278-84.
Score: 0.016
-
Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002 Sep 17; 137(6):529-41.
Score: 0.016
-
Evaluating information loss in the National Cancer Database from cases lost to follow-up. J Surg Oncol. 2022 Nov; 126(6):1123-1132.
Score: 0.016
-
Postmenopausal hormone replacement therapy: scientific review. JAMA. 2002 Aug 21; 288(7):872-81.
Score: 0.016
-
Assessing benefits and harms of hormone replacement therapy: clinical applications. JAMA. 2002 Aug 21; 288(7):882-4.
Score: 0.016
-
Preventing Obesity in Midlife Women: A Systematic Review for the Women's Preventive Services Initiative. Ann Intern Med. 2022 09; 175(9):1275-1284.
Score: 0.016
-
Preventing Obesity in Midlife Women: A Recommendation From the Women's Preventive Services Initiative. Ann Intern Med. 2022 09; 175(9):1305-1309.
Score: 0.016
-
Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2002 May 07; 136(9):680-90.
Score: 0.016
-
"Answers in hours": A prospective clinical study using nanopore sequencing for bile duct cultures. Surgery. 2022 03; 171(3):693-702.
Score: 0.015
-
Screening for Chlamydial and Gonococcal Infections: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021 09 14; 326(10):957-966.
Score: 0.015
-
Trends in Patient Volume by Hospital Type and the Association of These Trends With Time to Cancer Treatment Initiation. JAMA Netw Open. 2021 07 01; 4(7):e2115675.
Score: 0.015
-
Extrapolation of ACOSOG Z0011 trial results-A survey of breast cancer providers. Breast J. 2021 06; 27(6):537-542.
Score: 0.014
-
Uptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers. Ann Surg Oncol. 2021 Sep; 28(9):4995-5004.
Score: 0.014
-
The intersection of tumor location and combined bowel preparation: Utilization differs but anastomotic leak risk reduction does not. J Surg Oncol. 2021 Jan; 123(1):261-270.
Score: 0.014
-
Screening for Anxiety in Adolescent and Adult Women: A Recommendation From the Women's Preventive Services Initiative. Ann Intern Med. 2020 07 07; 173(1):48-56.
Score: 0.014
-
Survival After Cancer Treatment at Top-Ranked US Cancer Hospitals vs Affiliates of Top-Ranked Cancer Hospitals. JAMA Netw Open. 2020 05 01; 3(5):e203942.
Score: 0.014
-
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020 Jun; 181(3):487-497.
Score: 0.014
-
Workload Differentiates Breast Surgical Procedures: NSM Associated with Higher Workload Demand than SSM. Ann Surg Oncol. 2020 May; 27(5):1318-1326.
Score: 0.013
-
Postmenopause as a key factor in the composition of the Endometrial Cancer Microbiome (ECbiome). Sci Rep. 2019 12 16; 9(1):19213.
Score: 0.013
-
Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance). Ann Surg Oncol. 2019 Dec; 26(13):4213-4221.
Score: 0.013
-
Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions. JAMA Netw Open. 2019 10 02; 2(10):e1912597.
Score: 0.013
-
Women's Preventive Services Initiative's Well-Woman Chart: A Summary of Preventive Health Recommendations for Women. Obstet Gynecol. 2019 09; 134(3):465-469.
Score: 0.013
-
An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study. Inflamm Bowel Dis. 2019 04 11; 25(5):902-913.
Score: 0.013
-
Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers. Genome Med. 2018 10 31; 10(1):78.
Score: 0.012
-
Short interpregnancy intervals and adverse perinatal outcomes in high-resource settings: An updated systematic review. Paediatr Perinat Epidemiol. 2019 01; 33(1):O25-O47.
Score: 0.012
-
Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea. Sci Transl Med. 2018 10 24; 10(464).
Score: 0.012
-
Short interpregnancy intervals and adverse maternal outcomes in high-resource settings: An updated systematic review. Paediatr Perinat Epidemiol. 2019 01; 33(1):O48-O59.
Score: 0.012
-
Good practices for the design, analysis, and interpretation of observational studies on birth spacing and perinatal health outcomes. Paediatr Perinat Epidemiol. 2019 01; 33(1):O15-O24.
Score: 0.012
-
Report of the Office of Population Affairs' expert work group meeting on short birth spacing and adverse pregnancy outcomes: Methodological quality of existing studies and future directions for research. Paediatr Perinat Epidemiol. 2019 01; 33(1):O5-O14.
Score: 0.012
-
Accuracy of Digital Pathologic Analysis vs Traditional Microscopy in the Interpretation of Melanocytic Lesions. JAMA Dermatol. 2018 10 01; 154(10):1159-1166.
Score: 0.012
-
Malpractice Concerns, Defensive Medicine, and the Histopathology Diagnosis of Melanocytic Skin Lesions. Am J Clin Pathol. 2018 Aug 30; 150(4):338-345.
Score: 0.012
-
Screening for Urinary Incontinence in Women: A Recommendation From the Women's Preventive Services Initiative. Ann Intern Med. 2018 09 04; 169(5):320-328.
Score: 0.012
-
Characteristics and diagnostic performance of pathologists who enjoy interpreting melanocytic lesions. Dermatol Online J. 2018 Jun 15; 24(6).
Score: 0.012
-
Synthesis of multi-omic data and community metabolic models reveals insights into the role of hydrogen sulfide in colon cancer. Methods. 2018 10 01; 149:59-68.
Score: 0.012
-
Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation. J Am Acad Dermatol. 2018 Jul; 79(1):52-59.e5.
Score: 0.012
-
Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs. Breast Cancer Res Treat. 2018 01; 167(1):195-203.
Score: 0.011
-
Molecular epidemiology of Staphylococcus aureus bacteremia in a single large Minnesota medical center in 2015 as assessed using MLST, core genome MLST and spa typing. PLoS One. 2017; 12(6):e0179003.
Score: 0.011
-
The diagnostic challenge of low-grade ductal carcinoma in situ. Eur J Cancer. 2017 07; 80:39-47.
Score: 0.011
-
Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease. Microbiome. 2017 05 15; 5(1):55.
Score: 0.011
-
Surgical implications and variability in the use of the flat epithelial atypia diagnosis on breast biopsy specimens. Breast. 2017 Aug; 34:34-43.
Score: 0.011
-
Characteristics associated with requests by pathologists for second opinions on breast biopsies. J Clin Pathol. 2017 Nov; 70(11):947-953.
Score: 0.011
-
Comparison of Fecal Collection Methods for Microbiota Studies in Bangladesh. Appl Environ Microbiol. 2017 05 15; 83(10).
Score: 0.011
-
Outcomes of Primary Colorectal Sarcoma: A National Cancer Data Base (NCDB) Review. J Gastrointest Surg. 2017 03; 21(3):560-568.
Score: 0.011
-
Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time? Ann Surg Oncol. 2017 May; 24(5):1234-1241.
Score: 0.011
-
The influence of tumor regression, solar elastosis, and patient age on pathologists' interpretation of melanocytic skin lesions. Lab Invest. 2017 02; 97(2):187-193.
Score: 0.011
-
Potential contribution of the uterine microbiome in the development of endometrial cancer. Genome Med. 2016 11 25; 8(1):122.
Score: 0.011
-
Shifts in the Fecal Microbiota Associated with Adenomatous Polyps. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):85-94.
Score: 0.011
-
Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 2016 11; 25(11):1483-1490.
Score: 0.011
-
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep. 2016 06 27; 6:28484.
Score: 0.010
-
Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study. BMJ. 2016 Jun 22; 353:i3069.
Score: 0.010
-
The Influence of Disease Severity of Preceding Clinical Cases on Pathologists' Medical Decision Making. Med Decis Making. 2017 01; 37(1):91-100.
Score: 0.010
-
Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective. Ann Intern Med. 2016 05 17; 164(10):649-55.
Score: 0.010
-
Medical malpractice concerns and defensive medicine: a nationwide survey of breast pathologists. Am J Clin Pathol. 2015 Dec; 144(6):916-22.
Score: 0.010
-
How concerns and experiences with medical malpractice affect dermatopathologists' perceptions of their diagnostic practices when interpreting cutaneous melanocytic lesions. J Am Acad Dermatol. 2016 Feb; 74(2):317-24; quiz 324.e1-8.
Score: 0.010
-
Diagnostic concordance among pathologists interpreting breast biopsy specimens. JAMA. 2015 Mar 17; 313(11):1122-32.
Score: 0.010
-
Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium. Cancer. 2015 May 01; 121(9):1369-78.
Score: 0.009
-
Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response. Breast. 2015 Feb; 24(1):3-11.
Score: 0.009
-
Digitized whole slides for breast pathology interpretation: current practices and perceptions. J Digit Imaging. 2014 Oct; 27(5):642-8.
Score: 0.009
-
Second opinion in breast pathology: policy, practice and perception. J Clin Pathol. 2014 Nov; 67(11):955-60.
Score: 0.009
-
A framework for evaluating diagnostic discordance in pathology discovered during research studies. Arch Pathol Lab Med. 2014 Jul; 138(7):955-61.
Score: 0.009
-
Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies. Breast Cancer Res Treat. 2014 May; 145(1):165-75.
Score: 0.009
-
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013 Oct 09; 310(14):1455-61.
Score: 0.009
-
Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS). BMC Womens Health. 2013 Feb 05; 13:3.
Score: 0.008
-
Surgical menopause and nonvertebral fracture risk among older US women. Menopause. 2012 May; 19(5):510-6.
Score: 0.008
-
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med. 2012 May 01; 156(9):609-17.
Score: 0.008
-
Long-term follow-up and individual item analysis of quality of life assessments related to laparoscopic-assisted colectomy in the COST trial 93-46-53 (INT 0146). Ann Surg Oncol. 2011 Sep; 18(9):2422-31.
Score: 0.007
-
Laparoscopic-assisted vs. open colectomy for cancer: comparison of short-term outcomes from 121 hospitals. J Gastrointest Surg. 2008 Nov; 12(11):2001-9.
Score: 0.006
-
USPSTF recommendations for STI screening. Am Fam Physician. 2008 Mar 15; 77(6):819-24.
Score: 0.006
-
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA. 2007 Aug 15; 298(7):754-64.
Score: 0.006
-
Is en-bloc resection of locally recurrent rectal carcinoma involving the urinary tract indicated? Ann Surg Oncol. 2006 May; 13(5):740-4.
Score: 0.005
-
Economic comparison of diagnostic approaches for evaluating osteoporosis in older women. Osteoporos Int. 2006 Jan; 17(1):68-76.
Score: 0.005
-
The Mayo Clinic experience with multimodality treatment of locally advanced or recurrent colon cancer. Ann Surg Oncol. 2002 Mar; 9(2):177-85.
Score: 0.004
-
Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial. JAMA. 2002 Jan 16; 287(3):321-8.
Score: 0.004